Blood Clot Crisis? COVID-19 Causes More Clots than Vaccines, Moderna and Pfizer Vaccines Cause As Many Clots As Troubled AstraZeneca Product, While J&J Remains on Hold

Blood Clot Crisis COVID-19 Causes More Clots than Vaccines, Moderna and Pfizer Vaccines Cause As Many Clots As Troubled AstraZeneca Product, While J&J Remains on Hold

As we know, the FDA has halted the use of the Johnson & Johnson vaccine due to the risk of blood clots. This issue is becoming more complex, as evidence is showing that both the Moderna and Pfizer products cause many times more clots than AstraZeneca’s not-yet-US-approved vaccine, which in turn is facing the same blood clot issues as J&J. And a separate issue, the fact that catching COVID-19 will raise your clot risk more than any vaccine, is being headlined by Oxford University in their April 15 discussion of these issues. They note that researchers at that institution have reported that the risk of the clotting known as CVT, or cerebral venous thrombosis, among COVID-19 patients is about 10 times higher than among the vaccinated and about 100 times higher than the risk of this disorder in the general public. Oxford quotes one researcher, “We’ve reached two important conclusions. Firstly, COVID-19 markedly increases the risk of CVT, adding to the list of blood clotting problems this infection causes. Secondly, the COVID-19 risk is higher than we see with the current vaccines, even for those under 30; something that should be taken into account when con...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee